Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Preveceutical Medical Inc PRVCF


Primary Symbol: C.PREV

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based... see more

Recent & Breaking News (CSE:PREV)

BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors

Newsfile 3 days ago

BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board

Newsfile 7 days ago

PreveCeutical's Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer

Newsfile 10 days ago

PreveCeutical Announces Closing of BioGene Therapeutics Transaction

Newsfile 13 days ago

PreveCeutical's Subsidiary, BioGene Therapeutics, Appoints President

Newsfile November 13, 2024

PreveCeutical Launches Strategic Partnership with BioGene Therapeutics

Newsfile October 30, 2024

PreveCeutical Engages Phoenix Corporate Finance Inc. to Provide Advisory Services

Newsfile October 18, 2024

PreveCeutical Engages Outside The Box Capital Inc. to Provide Marketing Services

Newsfile September 3, 2024

Preveceutical Announces Revocation of Management Cease Trade Order

Newsfile July 9, 2024

PreveCeutical Provides Update on Management Cease Trade Order

Newsfile June 28, 2024

PreveCeutical Enters into Loan Agreements

Newsfile June 17, 2024

PreveCeutical Provides Update on Management Cease Trade Order

Newsfile June 14, 2024

PreveCeutical Commences Litigation Against Former Legal Counsel in the British Columbia Supreme Court Alleging Professional Negligence

Newsfile June 6, 2024

Preveceutical Provides Update on Management Cease Trade Order

Newsfile May 30, 2024

Preveceutical Announces First Tranche Closing of Private Placement

Newsfile May 29, 2024

PreveCeutical Provides Update on Management Cease Trade Order

Newsfile May 16, 2024

PreveCeutical Announces Management Cease Trade Order

Newsfile May 2, 2024

PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM

PR Newswire December 4, 2023

PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application

PR Newswire September 18, 2023

PreveCeutical Showcases Dynamic Evolution in AI Strategy

PR Newswire September 12, 2023